| Zahidul Islam Chowdhury, MD | |
|
240 N Highland Ave Ne, Suite F, Atlanta, GA 30307-5609 | |
| (404) 658-9840 | |
| (404) 658-9846 |
| Full Name | Zahidul Islam Chowdhury |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 240 N Highland Ave Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023458890 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 074712 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Medical Care Corporation | 6002802220 | 265 |
News Archive
Frontotemporal dementia and amyotrophic lateral sclerosis, also known as Lou Gehrig's disease - two fatal neurodegenerative disease with distinct but sometimes overlapping symptoms - are triggered by a common mutation in many cases, according to researchers who say they have identified the mutated gene.
Ultradian Diagnostics LLC, an early-stage medical device company based in Rensselaer, New York, today announced the publication of clinical study results for Biologue, the Company's minimally invasive continuous glucose monitoring (CGM) system, in the November 2012 issue of the Journal of Diabetes Science and Technology.
Officials say the interim rule, published Tuesday, will streamline electronic billing for doctors and save time and money.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that data demonstrating preclinical efficacy of Chimerix's lead antiviral compound CMX001 against herpes simplex virus (HSV) as well as its ability to penetrate the blood-brain barrier was published in the November 15, 2010 issue of The Journal of Infectious Diseases.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 7 days ago
| Entity Name | Piedmont Medical Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912956046 PECOS PAC ID: 6002802220 Enrollment ID: O20040422001500 |
News Archive
Frontotemporal dementia and amyotrophic lateral sclerosis, also known as Lou Gehrig's disease - two fatal neurodegenerative disease with distinct but sometimes overlapping symptoms - are triggered by a common mutation in many cases, according to researchers who say they have identified the mutated gene.
Ultradian Diagnostics LLC, an early-stage medical device company based in Rensselaer, New York, today announced the publication of clinical study results for Biologue, the Company's minimally invasive continuous glucose monitoring (CGM) system, in the November 2012 issue of the Journal of Diabetes Science and Technology.
Officials say the interim rule, published Tuesday, will streamline electronic billing for doctors and save time and money.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that data demonstrating preclinical efficacy of Chimerix's lead antiviral compound CMX001 against herpes simplex virus (HSV) as well as its ability to penetrate the blood-brain barrier was published in the November 15, 2010 issue of The Journal of Infectious Diseases.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zahidul Islam Chowdhury, MD 240 N Highland Ave Ne, Suite F, Atlanta, GA 30307-5609 Ph: (404) 658-9840 | Zahidul Islam Chowdhury, MD 240 N Highland Ave Ne, Suite F, Atlanta, GA 30307-5609 Ph: (404) 658-9840 |
News Archive
Frontotemporal dementia and amyotrophic lateral sclerosis, also known as Lou Gehrig's disease - two fatal neurodegenerative disease with distinct but sometimes overlapping symptoms - are triggered by a common mutation in many cases, according to researchers who say they have identified the mutated gene.
Ultradian Diagnostics LLC, an early-stage medical device company based in Rensselaer, New York, today announced the publication of clinical study results for Biologue, the Company's minimally invasive continuous glucose monitoring (CGM) system, in the November 2012 issue of the Journal of Diabetes Science and Technology.
Officials say the interim rule, published Tuesday, will streamline electronic billing for doctors and save time and money.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that data demonstrating preclinical efficacy of Chimerix's lead antiviral compound CMX001 against herpes simplex virus (HSV) as well as its ability to penetrate the blood-brain barrier was published in the November 15, 2010 issue of The Journal of Infectious Diseases.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the completion of enrollment of and first treatment visits for participants in its histology study (IT-H-001) of azficel-T. An autologous cell therapy, azficel-T is currently under review by the U.S. Food and Drug Administration for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 7 days ago
Fidelia O Osinubi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3885 Princeton Lakes Way, Suite 402, Atlanta, GA 30331 Phone: 404-349-0496 Fax: 404-349-6081 | |
Theresa R Jacobs, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 868 York Ave Sw, Atlanta, GA 30310 Phone: 404-752-1400 Fax: 404-758-0740 | |
David M Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1046 Ridge Ave Sw, Atlanta, GA 30315 Phone: 404-688-1350 Fax: 404-564-6734 | |
Tony Serrano-padin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1701 Hardee Ave. Sw, Bldg 125, Fort Mcpherson - Army Health Clinic, Atlanta, GA 30330 Phone: 404-464-0389 | |
Dr. Bhavi Patel Purohit, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Westview Dr Sw, Atlanta, GA 30310 Phone: 404-756-1230 Fax: 404-752-8682 | |
Dr. Edmond Shih, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5461 Buford Hwy Ne, Atlanta, GA 30340 Phone: 770-457-5556 Fax: 770-457-7776 |